Senior Director, Clinical Operations Compliance Management (Gcp/Biotechnology/Oncology) Exelixis Inc.Senior Director, Clinical Operations Compliance Management (Gcp/Biotechnology/Oncology)Alameda, CA$246,000–$349,500 / yearThe Senior Director of COCM is a key partner with our Quality Assurance team and other functional groups (including Clinical Development, Data Management, etc.) and is responsible for supporting inspection readiness activities, driving cross-study consistency in study execution and compliance with governing functional procedures and processes, and escalation of identified operational issues within development and of identified quality issues to QA. EDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education: Bachelor's degree in related discipline and a minimum of 15 years of related experience; or, Master's degree in related discipline and a minimum of 13 years of related experience; or, Doctoral degree in related discipline and a minimum of 12 years of related experience; or, Equivalent combination of education and experience.
Associate Director, Quality Assurance Compliance Gilead Sciences IncAssociate Director, Quality Assurance ComplianceFoster City, CAAs an Associate Director, Quality Assurance Compliance at Gilead you will have the following responsibilities: Inspection Operation and Logistics (Foster City): Manages the logistics to support regulatory inspections at GSI Foster City including notification process, inspection support team (IST), prep room and inspection rooms and post-inspection activities. Coordinate site inspection logistics with the different cross functional groups including general notification, investigator needs, conference room set-up (printers, boards, zoom, phones, office supplies, laptops, iPad/cart for virtual tours) and inspection support team assignment and schedule.
Director of Governance, Risk, and Compliance Elise A.I. Technologies Corp.Director of Governance, Risk, and ComplianceSan Francisco, CA$200,000–$275,000 / yearYou will work cross-functionally with Security Engineering, Legal, and business stakeholders to operationalize compliance efforts, support audits, and manage the GRC team to respond to customer and vendor due diligence requests. Own and lead the companys GRC program, setting strategic direction across frameworks including SOC 1, SOC 2, PCI, HITRUST, and HIPAA.
Director, Federal Compliance Super Micro Computer IncDirector, Federal ComplianceSan Jose, CA$200,000–$232,000 / yearAbout Supermicro: Supermicro is a Top Tier provider of advanced server, storage, and networking solutions for Data Center, Cloud Computing, Enterprise IT, Hadoop/ Big Data, Hyperscale, HPC and IoT/Embedded customers worldwide. Collaborate cross-functionally with sales, engineering, operations, legal, and HR teams on federal-specific initiatives, including product certifications, sustainability reporting, business continuity, whistleblower programs, and code of conduct enforcement in the federal context.
Director of Grants, Contracts & Financial Compliance GlideDirector of Grants, Contracts & Financial ComplianceSan Francisco, CaliforniaPosition Summary : The Director of Grants, Contracts & Financial Compliance (internally known as the Director of Grants & Contracts) provides strategic leadership and oversight of the organization's government contracts, grants, and restricted funding portfolio, including financial compliance, contract billing, reimbursement processes, budget oversight, and fiscal risk management. The ideal candidate will have a deep background in government-funded financial management, grants and contracts administration, financial compliance, and general business analysis, with demonstrated experience managing teams and collaborating across functions.
Director, Global Compliance Visa Technology and Operations LLCDirector, Global ComplianceFoster City, CA$188,400–$301,500 / yearThis role sits within the Global Interchange organization and serves as the Director of Global Compliance, responsible for ensuring that proper levels of interchange are paid and received by Visa’s clients worldwide and that Visa’s systems, processes, and controls operate as intended across all regions. Visa is a world leader in payments technology, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories, dedicated to uplifting everyone, everywhere by being the best way to pay and be paid.
Director, Compliance Counsel Denali Therapeutics IncDirector, Compliance CounselSouth San Francisco, CA$243,000–$299,000 / yearDenali is founded on the collaboration of leading scientists, industry experts, and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients. Provide strategic guidance on emerging healthcare compliance risks, including clinical trials, patient support programs, expanded access programs, and commercialization strategies.
Director, Compliance & Control Oversight - Growth Upstart Holdings IncDirector, Compliance & Control Oversight - GrowthCARemote$201,200–$278,500 / yearThe Director, Compliance & Controls - Growth leads first-line compliance for Upstart's growth engine: the acquisition channels, marketing programs, partner relationships, and product launches that bring borrowers to our platform across unsecured lending (personal loans and lines), servicing, and growth (for both unsecured and secured products). Channel & partner oversight: Own first-line compliance and controls for the growth function - acquisition channels, marketing programs (social, direct mail, email, co-branded), partner and affiliate relationships, and new product introductions - reviewing each for regulatory, fair lending, and disclosure risk, and approving marketing materials and third-party-produced content before release.
Associate Director, Compliance, Field Commercialization (West) Revolution Medicines, Inc.Associate Director, Compliance, Field Commercialization (West)Redwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Reporting to the Senior Director, Compliance, the Associate Director will lead the development, implementation, and continuous enhancement of a comprehensive field compliance program, embedding compliance into field operations and supporting the company's growth as a commercial-stage oncology organization.
Executive Director, Gxp Quality And Compliance Revolution Medicines, Inc.Executive Director, Gxp Quality And ComplianceRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Preferred Skills: Experience leading global GxP compliance programs across both clinical development and commercial product environments, including inspection readiness, launch readiness, and post-approval compliance oversight.
NewDirector, Compliance Risk QcellsDirector, Compliance RiskSanta Clara, CAFull timeBachelor’s degree or equivalent work experience and a minimum of 12+ years of professional work experience including 10+ years of experience in consumer lending regulatory compliance, preferably within fintech and/or bank partnership models and 5+ years of progressive leadership experience with direct people/team management. Mobility Standing 20% of time Sitting 70% of time Walking 10% of time Strength Pulling up to 10 Pounds Pushing up to 10 Pounds Carrying up to 10 Pounds Lifting up to 10 Pounds Dexterity (F = Frequently, O = Occasionally, N = Never) Typing F Handling F Reaching F Agility (F = Frequently, O = Occasionally, N = Never) Turning F Twisting F Bending O Crouching O Balancing N Climbing N Crawling N Kneeling N .
Senior Director, Compliance Training Revolution Medicines, Inc.Senior Director, Compliance TrainingRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner closely with Learning & Development, Corporate Communications, Legal, HR, regional compliance staff (U.S., Europe, and Asia), and business stakeholders to ensure effective deployment, localization, communication, and reinforcement of training programs.
Associate Director, Global Healthcare Compliance Operations Revolution Medicines, Inc.Associate Director, Global Healthcare Compliance OperationsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Lead implementation, enhancement, validation, and lifecycle management of systems supporting HCP/HCO engagements, advisory boards, speaker programs, grants and sponsorships, third-party due diligence, transparency reporting, monitoring and auditing activities, compliance training and certifications.
Senior Director, US Compliance Revolution Medicines, Inc.Senior Director, US ComplianceRedwood City, CA$244,000–$305,000 / yearAreas of focus include: Serve as the strategic compliance advisor to Commercial, Medical Affairs, Market Access, Patient Services, and other field-facing functions by proactively identifying compliance risks, enabling compliant business solutions, and embedding compliance into key business decisions throughout commercialization and product launch. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director, Associate General Counsel - Corporate Compliance Form EnergyDirector, Associate General Counsel - Corporate ComplianceBerkeley, CAIn recent years, Form Energy has earned a number of accolades, including being named by TIME as a "Best Invention", MIT Technology Review as a "Top Climate Tech Company To Watch", and Fast Company as "One of the Next Big Things In Tech". Monitor regulatory developments affecting Form Energy's business, including changes to securities laws, energy regulations, government contracting requirements, and environmental rules, and advise the legal team and business accordingly.
Senior Director, Compliance GoFundMe, Inc.Senior Director, ComplianceSan Francisco, CA$253,000–$380,000 / yearEstablish defensible governance, QA, issue management, remediation, and examination-readiness processes for AML/FinCrime controls, including transaction monitoring, STR/SAR decisioning, sanctions/listed property escalation, management reporting, and evidence of operating effectiveness. Demonstrated ability to build and maintain productive, strategic relationships with regulatory counterparts; comfort engaging directly with regulators at executive levels - including examinations, inquiries, and proactive relationship management.
Director, Associate General Counsel - Corporate Compliance Form Energy IncDirector, Associate General Counsel - Corporate ComplianceBerkeley, CAMonitor regulatory developments affecting Form Energys business, including changes to securities laws, energy regulations, government contracting requirements, and environmental rules, and advise the legal team and business accordingly. In recent years, Form Energy has earned a number of accolades, including being named by TIME as a "Best Invention", MIT Technology Review as a "Top Climate Tech Company To Watch", and Fast Company as "One of the Next Big Things In Tech".
Director, Internal Audit - Compliance NVIDIA CorpDirector, Internal Audit - ComplianceSanta Clara, CADesign and supervise audits covering global trade compliance, anti-bribery and anti-corruption (FCPA, UK Bribery Act), data privacy (GDPR, CCPA/CPRA), and antitrust/competition law adherence. Demonstrated ability to build and maintain a dynamic, risk-based audit plan that reflects current business risk, integrating inputs from ERM, and business/executive leadership.
Senior Director, Regulatory Affairs Policy, Regulatory Intelligence & Compliance Exelixis IncSenior Director, Regulatory Affairs Policy, Regulatory Intelligence & ComplianceAlameda, CAThe position oversees the surveillance, triage, interpretation, and dissemination of global regulatory intelligence across Research & Development (R&D), Quality (QA), Information Technology (IT) and Pharmaceutical Supply Chain (PSC), partnering with cross-functional subject matter experts to ensure impact assessments are conducted and documented. EDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education: BA/BA degree in related discipline and 15 years of related experience; or, MA/MA degree in related discipline and 13 years of related experience; or, PhD in related discipline and 12 years of related experience; or, Equivalent combination of education and experience.
Director, Clinical Compliance Jade BiosciencesDirector, Clinical ComplianceSan Francisco, CaliforniaRemoteEmbedded within the Development Operations Operational Excellence team, this role functions as an internal GCP compliance leader who partners closely with study teams, vendors, and Quality Assurance (QA) to maintain inspection readiness and operational quality across all clinical programs. Support study teams in identifying and appropriately escalating significant compliance issues, protocol deviations, and site noncompliance, ensuring issues are investigated, documented, and resolved in accordance with regulatory expectations.
Executive Director, Global Patient Safety Quality and Compliance - Pharmacovigilance Revolution MedicinesExecutive Director, Global Patient Safety Quality and Compliance - PharmacovigilanceRedwood City, California$265,000–$331,000 / yearThe responsibilities of this role include oversight of the PV-QMS, PV training strategy, PV controlled documentation, inspection and audit management, ensuring inspection readiness, Corrective Action Preventive Action (CAPA) management, Quality Assurance (QA), and maintenance of Good Clinical Practice (GCP), and Good Pharmacovigilance Practices (GVP) in partnership with GPS management, QA, and staff. This critical role will require strategic thinking, expert knowledge of global PV regulations (i.e. GCP, GVP), the ability to influence and communicate ideas effectively, results orientation, collaboration with cross-functional teams, technical expertise, and vendor management skills to ensure compliance with regulatory requirements to safeguard patient well-being.
Executive Director, Global Patient Safety Quality and Compliance - Pharmacovigilance Revolution Medicines IncExecutive Director, Global Patient Safety Quality and Compliance - PharmacovigilanceRedwood City, CA$265,000–$331,000 / yearThe responsibilities of this role include oversight of the PV-QMS, PV training strategy, PV controlled documentation, inspection and audit management, ensuring inspection readiness, Corrective Action Preventive Action (CAPA) management, Quality Assurance (QA), and maintenance of Good Clinical Practice (GCP), and Good Pharmacovigilance Practices (GVP) in partnership with GPS management, QA, and staff. This critical role will require strategic thinking, expert knowledge of global PV regulations (i.e. GCP, GVP), the ability to influence and communicate ideas effectively, results orientation, collaboration with cross-functional teams, technical expertise, and vendor management skills to ensure compliance with regulatory requirements to safeguard patient well-being.
Director, Global Interchange Compliance Visa IncDirector, Global Interchange ComplianceFoster City, CA$188,400–$301,500 / yearThis role sits within the Global Interchange organization and serves as the Director of Global Interchange Compliance, responsible for ensuring that proper levels of interchange are paid and received by Visa's clients worldwide and that Visa's systems, processes, and controls operate as intended across all regions. Visa is a world leader in payments technology, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories, dedicated to uplifting everyone, everywhere by being the best way to pay and be paid.
Senior Director, Global Patient Safety Quality and Compliance Revolution Medicines IncSenior Director, Global Patient Safety Quality and ComplianceRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Senior Director will provide broad oversight across case processing, vendor governance, safety systems and processes, aggregate reporting operations, partner interfaces, and operational readiness while developing leaders and serving as a key advisor to cross-functional stakeholders.
Senior Director, Global Patient Safety Quality and Compliance Revolution MedicinesSenior Director, Global Patient Safety Quality and ComplianceRedwood City, California$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Senior Director will provide broad oversight across case processing, vendor governance, safety systems and processes, aggregate reporting operations, partner interfaces, and operational readiness while developing leaders and serving as a key advisor to cross-functional stakeholders.
Director, Internal Audit, Advisory, & Compliance Resources Connection IncDirector, Internal Audit, Advisory, & ComplianceSan Francisco, CA$172,000–$215,000 / yearWe are seeking a Director, Internal Audit, Advisory, and Compliance who will be responsible for supporting business development as well as leading, managing and, when necessary, executing projects in the pursuit of delivery excellence across a portfolio of clients. We've built a global network of over 2,600 experts across four regions, providing a comprehensive suite of solutions across on-demand talent, next-generation consulting, and outsourced services to support organizations at every stage of their growth journey.
Associate Director, Clinical Operations Compliance & Training Revolution Medicines, Inc.Associate Director, Clinical Operations Compliance & TrainingRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Sr. Director, Compliance & Ethics Bloom Energy CorpSr. Director, Compliance & EthicsSan Jose, CA$246,800–$355,200 / yearOur cutting-edge solutions enable unparalleled "time-to-power" capabilities, reliability, and sustainability, ensuring our customers remain ahead in a world where soaring energy demand and intensifying energy scarcity are rapidly becoming the new norm. You will partner closely with Legal, Finance, Internal Audit, HR, IT, and commercial leaders to ensure compliance programs are well-designed, effective, practical, scalable, consistently monitored, and embedded into day-to-day operations.
Senior Director, Compliance GoFundMeSenior Director, ComplianceSan Francisco, CA$253,000–$380,000 / yearEstablish defensible governance, QA, issue management, remediation, and examination-readiness processes for AML/FinCrime controls, including transaction monitoring, STR/SAR decisioning, sanctions/listed property escalation, management reporting, and evidence of operating effectiveness. Demonstrated ability to build and maintain productive, strategic relationships with regulatory counterparts; comfort engaging directly with regulators at executive levels - including examinations, inquiries, and proactive relationship management.
NewAssociate Director, Compliance Systems GlideAssociate Director, Compliance SystemsSan Francisco, CaliforniaCompliance Systems & Infrastructure Support the CCIO to design, implement, and continuously improve the systems, tools, processes, and cross-functional coordination necessary for departments across GLIDE (Finance, Fund Development, Programs, Ops, HR, etc.) to effectively meet their compliance responsibilities. Position Summary : The Associate Director of Compliance Systems is responsible for designing, implementing, and continuously improving the organizational systems, tools, governance processes, and cross-functional operating practices that enable GLIDE to consistently meet contractual and grant compliance requirements.
Director, Control Room Compliance Royal Bank of CanadaDirector, Control Room ComplianceSan Francisco, CA$160,000–$260,000 / yearThis role is responsible for maintaining the firm''s Information Barriers to restrict the improper flow of information and prevent the misuse of material non-public information between the public side areas of the firm (e.g., Research, Sales & Trading) and the private side areas (e.g., Investment Banking, Corporate Banking, etc.). Maintaining a workplace where our employees feel supported to perform at their best, effectively collaborate, drive innovation, and grow professionally helps to bring our Purpose to life and create value for our clients and communities.
Senior Director, US Compliance Revolution MedicinesSenior Director, US ComplianceRedwood City, California$244,000–$305,000 / yearAreas of focus include: Serve as the strategic compliance advisor to Commercial, Medical Affairs, Market Access, Patient Services, and other field-facing functions by proactively identifying compliance risks, enabling compliant business solutions, and embedding compliance into key business decisions throughout commercialization and product launch. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Senior Director, Compliance Training Revolution MedicinesSenior Director, Compliance TrainingRedwood City, California$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner closely with Learning & Development, Corporate Communications, Legal, HR, regional compliance staff (U.S., Europe, and Asia), and business stakeholders to ensure effective deployment, localization, communication, and reinforcement of training programs.
Director, US Compliance Revolution MedicinesDirector, US ComplianceRedwood City, California$267,000–$306,000 / yearProvide timely, practical, and risk-based compliance advice and counsel on healthcare compliance and policy requirements related to Revolution Medicines interactions with the healthcare community, including disease education programs, promotional and nonpromotional activities, consulting engagements, advisory boards, external funding, patient assistance programs, patient advocacy group interactions, payer interactions, and other similar activities. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, Global Healthcare Compliance Operations Revolution MedicinesAssociate Director, Global Healthcare Compliance OperationsRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Lead implementation, enhancement, validation, and lifecycle management of systems supporting HCP/HCO engagements, advisory boards, speaker programs, grants and sponsorships, third-party due diligence, transparency reporting, monitoring and auditing activities, compliance training and certifications.
Senior Director, Compliance Revolution MedicinesSenior Director, ComplianceRedwood City, California$244,000–$305,000 / yearThe Senior Director, Compliance will support the Vice President, Compliance to implement and continuously enhance a comprehensive compliance program that spans healthcare, research, manufacturing, export controls, economic sanctions, trade and tariff-related compliance, general corporate compliance and other global business conduct requirements applicable to a growing multinational organization. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
NewExecutive Director, GxP Quality and Compliance Revolution MedicinesExecutive Director, GxP Quality and ComplianceRedwood City, California$265,000–$331,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. 15+ years of progressive experience in GxP Quality and Compliance within the pharmaceutical, biotechnology, medical device, or related life sciences industry with extensive knowledge of FDA regulations, ICH Guidelines, EU GMP, and global GxP requirements.
Associate Director, Global Healthcare Compliance Operations Revolution Medicines IncAssociate Director, Global Healthcare Compliance OperationsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Lead implementation, enhancement, validation, and lifecycle management of systems supporting HCP/HCO engagements, advisory boards, speaker programs, grants and sponsorships, third-party due diligence, transparency reporting, monitoring and auditing activities, compliance training and certifications.
Senior Director, US Compliance Revolution Medicines IncSenior Director, US ComplianceRedwood City, CA$244,000–$305,000 / yearAreas of focus include: Serve as the strategic compliance advisor to Commercial, Medical Affairs, Market Access, Patient Services, and other field-facing functions by proactively identifying compliance risks, enabling compliant business solutions, and embedding compliance into key business decisions throughout commercialization and product launch. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, Compliance, Field Commercialization (West) Revolution MedicinesAssociate Director, Compliance, Field Commercialization (West)Redwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Reporting to the Senior Director, Compliance, the Associate Director will lead the development, implementation, and continuous enhancement of a comprehensive field compliance program, embedding compliance into field operations and supporting the company's growth as a commercial-stage oncology organization.
Associate Director, Compliance, Field Commercialization West Revolution Medicines IncAssociate Director, Compliance, Field Commercialization WestRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Reporting to the Senior Director, Compliance, the Associate Director will lead the development, implementation, and continuous enhancement of a comprehensive field compliance program, embedding compliance into field operations and supporting the company''s growth as a commercial-stage oncology organization.
Executive Director, GxP Quality and Compliance Revolution Medicines IncExecutive Director, GxP Quality and ComplianceRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Preferred Skills: Experience leading global GxP compliance programs across both clinical development and commercial product environments, including inspection readiness, launch readiness, and post-approval compliance oversight.
Senior Director, Compliance Training Revolution Medicines IncSenior Director, Compliance TrainingRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner closely with Learning & Development, Corporate Communications, Legal, HR, regional compliance staff (U.S., Europe, and Asia), and business stakeholders to ensure effective deployment, localization, communication, and reinforcement of training programs.
Director, US Compliance Revolution Medicines IncDirector, US ComplianceRedwood City, CA$267,000–$306,000 / yearProvide timely, practical, and risk-based compliance advice and counsel on healthcare compliance and policy requirements related to Revolution Medicines interactions with the healthcare community, including disease education programs, promotional and nonpromotional activities, consulting engagements, advisory boards, external funding, patient assistance programs, patient advocacy group interactions, payer interactions, and other similar activities. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director, Project Leadership - Compliance PM & ALD Abbott LaboratoriesDirector, Project Leadership - Compliance PM & ALDAlameda, CA$172,000–$344,000 / yearOur portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Minimum 7 years experience in program/portfolio leadership within a global, matrixed team, preferably including experience with consumer-focused medical or software products.
Director, Project Leadership - Compliance PM & ALD AbbottDirector, Project Leadership - Compliance PM & ALDAlameda, CaliforniaOur portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Minimum 7 years experience in program/portfolio leadership within a global, matrixed team, preferably including experience with consumer-focused medical or software products.
Director, Customs Compliance - Americas Teledyne TechnologiesDirector, Customs Compliance - AmericasMountain View, CA$120,300–$160,400 / yearThese markets include aerospace and defense, factory automation, air and water quality environmental monitoring, electronics design and development, oceanographic research, deepwater oil and gas exploration and production, medical imaging and pharmaceutical research. The position requires deep technical expertise in customs classification, valuation, origin, free trade agreements, tariff mitigation, and audit management, as well as the ability to translate complex regulatory requirements into practical, business‑aligned solutions.
Associate Director, Clinical Operations Compliance & Training Revolution MedicinesAssociate Director, Clinical Operations Compliance & TrainingRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Associate Director, Clinical Operations Compliance & Training Revolution Medicines IncAssociate Director, Clinical Operations Compliance & TrainingRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Enhanced Compliance Consultant ComplySciEnhanced Compliance ConsultantSan Francisco, CA$88,000–$121,000 / yearComply serves thousands of global financial services clients including broker-dealers, insurers, investment banks, private funds, RIAs, and wealth managers who rely on Comply offerings to power their compliance programs. With more than 5,000 clients and hundreds of employees across the globe, Comply empowers Chief Compliance Officers and their teams to proactively manage regulatory obligations, mitigate risk, and scale with efficiency and confidence.